Japan Strengthens Regenerative Medicine Oversight

Douglas Sipp, Hideyuki Okano

Research output: Contribution to journal › Comment/debate

9 Citations (Scopus)

Abstract

The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

Original languageEnglish
Pages (from-to)153-156
Number of pages4
JournalCell Stem Cell
Volume22
Issue number2
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Regenerative Medicine
Japan
Stem Cell Research
Safety
Research
Surveys and Questionnaires

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Cite this

Japan Strengthens Regenerative Medicine Oversight. / Sipp, Douglas; Okano, Hideyuki.

In: Cell Stem Cell, Vol. 22, No. 2, 01.02.2018, p. 153-156.

Research output: Contribution to journal › Comment/debate

Sipp, D & Okano, H 2018, 'Japan Strengthens Regenerative Medicine Oversight', Cell Stem Cell, vol. 22, no. 2, pp. 153-156. https://doi.org/10.1016/j.stem.2018.01.001
Sipp D, Okano H. Japan Strengthens Regenerative Medicine Oversight. Cell Stem Cell. 2018 Feb 1;22(2):153-156. https://doi.org/10.1016/j.stem.2018.01.001
Sipp, Douglas ; Okano, Hideyuki. / Japan Strengthens Regenerative Medicine Oversight. In: Cell Stem Cell. 2018 ; Vol. 22, No. 2. pp. 153-156.
@article{83910fac4a5440f799cc975078f6bbc5,
title = "Japan Strengthens Regenerative Medicine Oversight",
abstract = "The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.",
author = "Douglas Sipp and Hideyuki Okano",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.stem.2018.01.001",
language = "English",
volume = "22",
pages = "153--156",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Japan Strengthens Regenerative Medicine Oversight

AU - Sipp, Douglas

AU - Okano, Hideyuki

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

AB - The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

UR - http://www.scopus.com/inward/record.url?scp=85045558136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045558136&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.01.001

DO - 10.1016/j.stem.2018.01.001

M3 - Comment/debate

C2 - 29395052

AN - SCOPUS:85045558136

VL - 22

SP - 153

EP - 156

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 2

ER -

Access to Document